Displaying items by tag: men

Are you between the ages of 11-19 with no history of mental health disorders?
Are you physically healthy?
If so, you may be eligible to participate in a study.
Compensation provided.
For more information, please call Brennan Wink at 205-975-4208 or send an
email to Brennanwink@uabmc.edu.

Published in Clinical Trials
Eligible participants must be healthy adults (BMI less than 45 kg/m2) and have no history of diabetes, heart problems, or kidney problems. The study involves consuming prepared meals, performing exercise on a treadmill, undergoing a glucose test, and collecting blood, urine samples, and collection of genetic information. Participants will be compensated $300 for completing all the visits and meals will be provided at no cost. Please e-mail us at, genesis@uabmc.edu or call us at (205) 975-3956 if you are interested.
Published in Clinical Trials
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
Published in Clinical Trials

We are looking for people with knee osteoarthritis to participate in a study to examine whether a diet intervention can reduce pain and improve quality of life. The commitment to this study will last approximately 7 weeks and include the following:

  • Five (5) visits to UAB where you will fill out questionnaires, complete a DEXA scan, blood draw or Quantitative Sensory testing. These visits will last anywhere from 1-3 hrs.
  • Six (6) weeks on a randomized diet where we will provide three (3) meals and two to three (2-3) snacks per day.

Participants must:

  • Be currently suffering from pain related to knee osteoarthritis
  • Be free from other serious health conditions (diabetes, cardiovascular disease, eating disorders, metabolic disease)

Participants will receive up to $250 for completing the study and meals will be provided. Please contact DIRECT at DIRECTPAIN1@gmail.com (205) 834-3628. Leave a short message with your name and number.

Published in Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in Clinical Trials
UAB researchers are looking for adults (ages 25-65) who are suffering from demoralization - feelings of hopelessness or meaninglessness - to participate in a research study evaluating a novel medication.

To see if you qualify call 205-379-7527.
Published in Clinical Trials

Help us find out by joining our study at UAB by participating in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.

Published in Clinical Trials
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
Published in Clinical Trials
Help us find out by joining our study at UAB You may be eligible to participate in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested
Published in Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in Clinical Trials
Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? Examples of some easily identifiable agitated behaviors are: restlessness, screaming, shouting, throwing things, resistiveness, constant unwarranted requests for attention or help, pacing/aimless wandering, kicking, hitting others or self, pushing people, hurting self or others, tearing things or destroying property. In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when compared to a placebo. If you are a caregiver for a person with Alzheimer’s disease, please call (205) 996-5987 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
Are you a HIV negative, generally healthy adult between the ages of 18-55?
The Alabama Vaccine Research Clinic at UAB are seeking volunteers for a phase 1 HIV prevention study. This study is to evaluate the safety and immunogenicity of synthetic DNAs encoding in adults without HIV. This trial is in search of healthy HIV negative adults between the ages of 18-55. Procedures will include blood draws and injections of study vaccine, as well as the collection of white blood cells. White blood cells will be collected by a procedure called leukapheresis. Participants will be compensated for their efforts in this study.

If you are interested, please call 205-934-6777 or email avrc@uabmc.edu.
You can also fill out our contact form at https://sites.uab.edu/avrc/contact-us/
Published in Clinical Trials
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Haley at 205-975-5825 or email us at nauticalstudy@uabmc.edu.
Published in Clinical Trials
The Functional Outcomes from Diet in Multiple Sclerosis (FOOD for MS) study will test whether eating healthy foods and losing weight can improve physical function, pain, fatigue, mood, and sleep in adults with relapsing-remitting or secondary progressing MS. We will also explore the how diet impacts inflammation, immunity, and metabolic biomarkers that may contribute to MS symptoms and progression. Eligible participants must be 18-65 years old, diagnosed with Relapsing Remitting Multiple Sclerosis or Secondary Progressive Multiple Sclerosis, and be able to travel to one of our two study sites, Birmingham, Alabama or St. Louis, Missouri three times points over 8 months. Participants will be compensated $150 for completing all study visits and have their groceries provided for the length of the study. Please contact Kathryn Green at kathryngreen@uabmc.edu or by phone 205-319-1424 or Meghan Taylor at meghan13@uab.edu for more information and to see if you qualify.
Published in Clinical Trials
Do you have a history of kidney stones?
If you are 18 or older with a history of calcium oxalate kidney stones, you may be eligible to participate in a research study. The goal of this study is to better understand how vitamin C is related to oxalate metabolism, an element of calcium oxalate kidney stone disease and how body weight impacts this. The study requires eating a study diet for 6 days, collecting 24-hr urines and blood samples with a one-day long visit at the UAB Clinical research unit. Study meals are provided free of charge and additional compensation up to $490 is offered.
For more information email kidneystone@uabmc.edu
Published in Clinical Trials
f you are 18 or older and in good health, you may be eligible to participate in a research study. The goal of this study is to better understand how vitamin C is related to oxalate metabolism, an element of calcium oxalate kidney stone disease and how body weight impacts this. The study requires eating a study diet for 6 days, collecting 24-hr urines and blood samples with a one-day long visit at the UAB Clinical research unit. Study meals are provided free of charge and additional compensation up to $490 is offered.
For more information email kidneystone@uabmc.edu
Published in Clinical Trials
Healthy adults needed for a study on vitamin C
If you are 18 or older and in good health, you may be eligible to participate in a research study. The goal of this study is to better understand how vitamin C is related to oxalate metabolism, an element of calcium oxalate kidney stone disease and how body weight impacts this. The study requires eating a study diet for 6 days, collecting 24-hr urines and blood samples with a one-day long visit at the UAB Clinical research unit. Study meals are provided free of charge and additional compensation up to $490 is offered.
For more information email kidneystone@uabmc.edu
Published in Clinical Trials
Eligible participants must be healthy adults (BMI less than 45 kg/m2) and have no history of diabetes, heart problems, or kidney problems. The study involves consuming prepared meals, performing exercise on a treadmill, undergoing a glucose test, and collecting blood, urine samples, and collection of genetic information. Participants will be compensated $300 for completing all the visits and meals will be provided at no cost. Please e-mail us at, genesis@uabmc.edu or call us at (205) 975-3956 if you are interested.
Published in Clinical Trials
We are conducting a research project to examine effects of a coach-guided videoconferencing acceptance and commitment therapy (ACT) program on improving psychological health (e.g., depressive symptoms) in persons with a spinal cord injury sustained within 5 years. You may qualify for the study if you are adults (age 18 or over) who had a traumatic or non-traumatic spinal cord injury within 5 years and have a web-enabled device (a computer/laptop, a smartphone, or a tablet PC) with the internet access at home. This study will involve completion of questionnaires three times and 8 weekly videoconferencing sessions by the ACT coach if you are assigned to the ACT group. Participants will be compensation at study completion (up to $215 as the ACT group). For questions and more information, contact Jessica Hawkins at jshawkins@uabmc.edu or 205-975-2882.
Published in Clinical Trials
Help us find out by joining our study at UAB You may be eligible to participate in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested
Published in Clinical Trials
We are looking for people who identify as trans or cisgender, are 18-65 years of age and would like to take part in a research study examining the impact of gender identity, hormone levels and sex assigned at birth to pain sensitivity and immune cell activity. The commitment to this study will last approximately 3 hours where you will fill out questionnaires, have a single blood draw and take part in pain sensitivity testing. Participants must: Be free from certain health conditions (HIX+, cardiovascular disease, uncontrolled hypertension). Participants can be on HRT (hormone replacement therapy) or not. Participants will receive up to $100. To find out more about this study, call 205-834-3625 or email shinestudyuab@gmail.com.
Published in Clinical Trials
We are conducting a research project to evaluate if coach-guided videoconferencing acceptance and commitment therapy (ACT) is effective for improving psychological health in family caregivers of people with dementia. You may qualify for the study if you are adults (age 18 or over) who are currently taking the primary responsibility for the care of a relative with dementia living in the community (i.e., your relative is not living in a nursing home) and have a web-enabled device (a computer/laptop, a smartphone, or a tablet PC) with the internet access at home. This study will involve completion of questionnaires three times and 10 weekly videoconferencing sessions by the ACT coach if you are assigned to the ACT group. Participants will be compensation at study completion (up to $150 as the ACT group). For questions and more information, contact Jessica Hawkins at jshawkins@uabmc.edu or 205-975-2882.
Published in Clinical Trials
We are conducting a research study to investigate how light-sensitive cells in the retina regulate eye growth and refractive errors like myopia (nearsightedness).


This study has been approved by the University of Alabama at Birmingham Institutional Review Board (ref: 300008644).


You will be eligible to participate in the study if you are:

-18-35 years old.

-You have corrected to normal vision (with glasses and contact lenses)

-You have good general and ocular health

This study includes a single visit that is expected to last 90 minutes or less. If eligible, you will be compensated $50.00 for your time and participation in the study.


Dr. Safal Khanal

Principal Investigator

Department of Optometry and Vision Science

University of Alabama at Birmingham


If you need more information or would like to participate in the study, please contact:

Dr. Safal Khanal

skhanal@uab.edu

(205) 934 4558
Published in Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in Clinical Trials
Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? Examples of some easily identifiable agitated behaviors are: restlessness, screaming, shouting, throwing things, resistiveness, constant unwarranted requests for attention or help, pacing/aimless wandering, kicking, hitting others or self, pushing people, hurting self or others, tearing things or destroying property. In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when compared to a placebo. If you are a caregiver for a person with Alzheimer’s disease, please call (205) 996-5987 or email lalexander@uabmc.edu for more information.
Published in Clinical Trials
Page 1 of 8